Zurueck zur Suche

Reporte zur Charge UJ515AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MO 8 CA 1

VAERS 1529401

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

moderat
Staat
CA
Alter
68,0
Geschlecht
F
Eingang
05.08.2021
Impfdatum
08.10.2020
Beginn
13.10.2020
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Clostridium test negative Dehydration Diarrhoea

Symptomtext

I started having diarrhea and my stomach being upset in October,2020,3 weeks after I received the vaccine. I had dehydration also.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
-
Labordaten
Clostridium difficult toxin/rflx PCs if ind. negative
Aktuelle Erkrankungen
Graves? disease, hyperthyroidism
Vorgeschichte
Graves? disease, hyperthyroidism, bronchial. - not sure what it is yet. CT scan in 4 more months.
Andere Medikamente
Calcium, vit d, selenium, lutein
Allergien
No
Vorherige Impfungen
-

VAERS 1842348

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
92,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Expired dose of FLUZONE HD vaccine was administered with no reported adverse event; Initial information received on 27-Oct-2021 regarding an unsolicited valid non-serious case from a other healthcare professional and consumer or other nonprofessional via Media information (under the reference 00829581). This case involves a 92-year-old female patient receiving expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [Frequency: once, strength: fluzone high dose, lot UJ515AA, expiry date: 30-Jun-2021] via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of actual medication error due to expired vaccine use (latency same day) The reporter reported "Nurse Practitioner reported that the FLUZONE High Dose vaccine from last year, which expired on 30-Jun-2021, was given to 8 patients." At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1842347

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
91,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

91 year old female patient received expired dose of FLUZONE HD vaccine with no reported adverse event; Initial information received on 27-Oct-2021 regarding an unsolicited valid non-serious case from a Physician via other healthcare professional via Medical Information (Reference number- 00829577). This case involves a 91 year old female patient who received expired dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient's medical history, medical treatment, vaccination, concomitant medication and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ515AA and expiry date: 30-Jun-2021) (Frequency: once) via an intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error case due to expired vaccine used (latency on same day). It was reported "Nurse Practitioner reported that the FLUZONE HD vaccine from last year, which expired on 30JUN2021, was given to 8 patients. The caller would like to know whether this dose should be counted and what the protocol is. There were no adverse reactions, treatment or ER (emergency room) visits reported post administration". This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839383

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) · Charge UJ515AA

gering
Staat
MO
Alter
-
Geschlecht
F
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE HD vaccine from last year, which expired on 30JUN2021 given to patient with no AE; Initial information received on 27-Oct-2021 regarding an unsolicited valid non-serious case received from a other health professional via number: 00829590. This case involves a 87 years old female patient who was administered an expired dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (expired product administered). The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number: UJ515AA and expiry date: 30-JUN-2021) via intramuscular route in in the left deltoid for prophylactic vaccination. It was case of an actual medication error due to expired vaccine used (latency: same day). At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839382

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) · Charge UJ515AA

gering
Staat
MO
Alter
85,0
Geschlecht
F
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE HD vaccine from last year, which expired with no reported adverse event; Initial information was regarding an unsolicited valid non serious case was received from a nurse via Medical Information (Reference number- 00829588) and transmitted to Sanofi on 27-Oct-2021 in a specific country. This case is linked to case 2021SA359222 (CLUSTER). This case involves an 85-year-old female patient who received INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Suspension for injection in pre-filled syringe, lot UJ515AA, expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error due to expired vaccine used. (latency: same day). It was reported "Nurse Practitioner reported that the FLUZONE HD vaccine from last year, which expired on 30JUN2021, was given to 8 patients. The caller would like to know whether this dose should be counted and what the protocol is." At time of reporting, no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839381

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
97,0
Geschlecht
F
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE HD vaccine from last year, which expired on 30JUN2021 with no reported adverse event; Initial information was received on 27-Oct-2021 regarding an unsolicited valid non-serious case from a nurse. This case involves a 97-year-old female patient who was administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] which was expired (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ515AA, expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day) It was reported "Nurse Practitioner reported that the FLUZONE HD vaccine from last year, which expired on 30JUN2021, was given to 8 patients. The caller would like to know whether this dose should be counted and what the protocol is." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839380

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
88,0
Geschlecht
F
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE HD vaccine from last year, which expired on 30-Jun-2021 was given with no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional via Medical Information (Reference number- 00829584) and transmitted to Sanofi on 27-Oct-2021 in a specific country. This case involves an 88-year-old female patient who vaccinated with expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] from last year [Batch number: UJ515AA and expiry date: 30-Jun-2021] (expired product administered). The patient, medical treatment(s), vaccination(s), and family history were not provided. No other concomitant vaccines were reported. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [lot UJ515AA and expiry date: 30-Jun-2021] via an intramuscular route in the left deltoid for prophylactic vaccination. It was a case of actual medication error due to expired product administered [Latency: on the the same day]. At time of reporting, the outcome was unknown for the event. At the time of report no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839379

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
89,0
Geschlecht
M
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

FLUZONE HD vaccine from last year, which expired with no reported adverse event; Initial information was received on 27-Oct-2021 regarding an unsolicited valid non-serious case from a nurse. This case involves a 89-year-old male patient who was administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] which was expired (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ515AA, expiry date:30-Jun-2021) via intramuscular route in the right deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day) It was reported "Nurse Practitioner reported that the FLUZONE HD vaccine from last year, which expired on 30JUN2021, was given to 8 patients. The caller would like to know whether this dose should be counted and what the protocol is." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839378

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ515AA

gering
Staat
MO
Alter
87,0
Geschlecht
M
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error

Symptomtext

8 patients received expired vaccine with no AE; Initial information was received on 26-Oct-2021 regarding an unsolicited valid non-serious case received from other healthcare professional via call center via Medical Information (Reference number- 00829571) in a specific country. This case involves an 87-year-old male patient who received expired vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided. On 26-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ515AA and expiry date: 30-Jun-2021) via an intramuscular route at an unknown administration site for prophylactic vaccination. It was an actual medication error case due to expired vaccine used (latency: same day). It was reported "Nurse Practitioner reported that the FLUZONE HD vaccine from last year, which expired on 30JUN2021, was given to 8 patients. The caller would like to know whether this dose should be counted and what the protocol is." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-